Infection Control
"Effectiveness of Measures to Prevent Spread of HIV but not Hepatitis C Among Australian IDUs."
Published in Hepatitis Weekly, July 22nd, 1996
According to an abstract submitted by the authors to the 11th International Conference on AIDS, held July 7-12, 1996, in Vancouver, British Columbia, "Objective: To facilitate minimization of spread of HIV and other blood borne viral infections (BBVIs) in Australian injecting drug users (IDUs) by assessing exposure to and risks of infection. Methods: This four city cross-sectional study conducted in 1994 recruited stratified samples designed to adequately represent women, youths, IDUs never previously in treatment and residents of outer suburbs. Respondents were recruited from diverse venues and were remunerated. Trained interviewers administered a questionnaire and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-07-22)
More Articles from Hepatitis Weekly
- Virology (HCV)
Absence of Anti-Core Antibody Linked to Immune System - Virology (HAV)
Simple, Nonradioactive Assay Enables Virus Titration Studies - Virology (HCV)
HCV Infection May Cause Mixed Cryoglobulinemia - At-Risk Populations
Chronic HCV Patients Should Receive HBV Vaccine - At-Risk Populations
Leprosy Patients at Risk for HCV/HGBV-C Infection - Blood Banking (Safety)
Risk of HIV, HTLV, HCV or HBV is Low - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
